Retinal dystrophies are a heterogeneous group of disorders of visual function leading to partial or complete blindness. We report the genetic basis of an unusual retinal dystrophy in five families with affected females and no affected males. Heterozygous missense variants were identified in the X-linked phosphoribosyl pyrophosphate synthetase 1 (PRPS1) Charcot-Marie-Tooth, and nonsyndromic sensorineural deafness. In our study families, affected females manifested a retinal dystrophy with interocular asymmetry. Three unrelated females from these families had hearing loss leading to a diagnosis of Usher syndrome. Other neurological manifestations were also observed in three individuals. Our data highlight the unexpected X-linked inheritance of retinal degeneration in females caused by variants in PRPS1 and suggest that tissue-specific skewed X-inactivation or variable levels of pyrophosphate synthetase-1
INTRODUCTION
Inherited retinal dystrophies (IRDs) are a heterogeneous group of visual function disorders that lead to partial or complete blindness, affecting approximately one in 2,500-3,000 individuals, and represent the commonest cause of blindness in the working age population and second commonest in childhood in England and Wales (Holt et al., 2015; Liew, Michaelides, & Bunce, 2014) . IRD may be classified according to whether there is a primary defect of cone or rod systems or both, and according to whether retinal dysfunction is generalized or confined to the central retina (macular dystrophy). These disorders can occur in isolation (nonsyndromic IRD) or with additional systemic manifestations (syndromic IRD). The genetic etiology of IRD is remarkably heterogeneous, with over 300 disease-causing genes identified (The Retinal Information Network, https://www.sph.uth.tmc.edu/RetNet/, accessed April 1, 2017). The implicated genes are involved in the function of numerous pathways in the retina, including phototransduction, retinal metabolism, ciliogenesis, and RNA splicing (Nash, Wright, Grigg, Bennetts, & Jamieson, 2015) ; however, the genetic cause of IRD in approximately 40% of cases remains unsolved (Ellingford et al., 2016; Khan et al., 2017) .
The identification of disease-causing variants in IRD has been accelerated by the implementation of next-generation sequencing (NGS) technologies. Targeted NGS sequencing of known genes can identify disease-causing variants in an estimated 60% of nonsyndromic cases and 80% of syndromic cases (Bravo-Gil et al., 2016; Ellingford et al., 2016; Glockle et al., 2014) . In patients that lack a molecular diagnosis, whole exome sequencing (WES) and whole genome sequencing (WGS) are effective tools to identify new potential causative genes and variants (Audo et al., 2014 (Audo et al., , 2016 Chaki et al., 2012 ).
In our collaborative study of unsolved IRD cases, through the UK Inherited Retinal Disease Consortium, the Japan Eye Genetic Consortium, and the 100,000 Genomes Project, approximately 1,614 unrelated individuals were analyzed by WES or WGS.
Here, we describe retinal dystrophy in nine affected females from five unrelated families with no affected males. WES or WGS revealed heterozygous missense variants in the phosphoribosyl pyrophosphate synthetase 1 (PRPS1) gene, which are more usually implicated in rare syndromic disease in male patients including Arts syndrome (MIM# 301835), X-linked Charcot-Marie-Tooth (CMTX5, MIM# 311070), and X-linked nonsyndromic sensorineural deafness (DFNX1, MIM# 304500).
MATERIALS AND METHODS

Clinical assessment of study families
The study protocols adhered to the tenets of the Declaration of (Bach et al., 2013; McCulloch et al., 2015) , with the exception of the flash ERGs in one child (2-IV:5), recorded using lower eyelid skin electrodes according to a pediatric protocol.
Next-generation sequencing
DNA samples for the five probands were analyzed by NGS: families 1, 2, 3, and 5 were investigated using WES and family 4 using WGS. For more details, see Supp. Materials and Methods.
F I G U R E 1
Retinal dystrophy pedigree structure and segregation of PRPS1 variants. Pedigrees of five study families (families 1-5) with affected females and no affected males. An arrow indicates the proband in each family. The PRPS1 variant identified in each family is indicated (position according to reference transcript NM_002764). Mut, PRPS1 causative variant present, WT, wild-type allele indicates that the disease status of the individual is unknown
Sanger sequencing
In order to confirm the PRPS1 variants identified by NGS (position according to reference transcript NM_002764 and X-chromosome co-ordinates in hg19), PCR amplification and bidirectional Sanger sequencing was performed using standard reagents and conditions, and oligonucleotide primers flanking the variant (primer sequences available on request). Segregation analysis was performed where familial samples were available.
In silico analysis of PRPS1 variants
The UCSC genome browser (https://genome.ucsc.edu/) and Phenopolis (https://Phenopolis.github.io; (Pontikos et al., 2017) ) were used for visualization and analysis of existing variation. Genetic variant deleteriousness was scored with PolyPhen v2.2.2 (https://genetics. bwh.harvard.edu/pph2/; accessed on 11/01/2017; Adzhubei et al., 2010) and SIFT (https://sift.jcvi.org/; accessed on 11/01/2017; Ng & Henikoff, 2001) . The evolutionary conservation of variants was assessed by multiple sequence alignment across species using 
RESULTS
Phenotypic characteristics
The phenotypic characteristics of nine affected individuals in the study families ( Figure 1 ) are summarized in Table 1 . The mean age in 2017 was 38 years with a range of 13-94 years. Photoaversion was reported in three patients (1-II:1, 3-II:1, and 5-II:2) and four subjects had night blindness (2-IV:5, 5-II:2, 5-III:1, and 5-III:2). Visual acuity reduction was described in three patients (2-III:4, 4-II:1, and 5-II:2), with one subject having blurred vision in the left eye due to intraocular lens dislocation (1-I:2).
Visual acuity varied; two patients had severe visual loss (less than 6/36 in the better eye) and six had relatively preserved BCVA (better than 6/9 in the better eye). The mean age of onset of visual symptoms was 19 years with a range of 5-29 years.
Fundus examination, color fundus photography, and FAF imaging identified a variable degree of patchy mid-peripheral retinal atrophy Electrophysiological assessment was performed in five patients and showed generalized retinal dysfunction with a similar degree of cone and rod photoreceptor involvement in two subjects (2-III:4 and 4-II:1), with mild worsening of rod system function in 4-II:1 between the ages of 6 and 12 years (Supp. Figure S1 ). In a 12-year-old girl there was ERG evidence of a cone-rod dystrophy (2-IV:5) and in one other subject a cone dystrophy (5-III:1). The ERGs were normal in one patient (5-III:2).
There was significant interocular ERG asymmetry in cases 2-III:4 (Supp. Figure S1 ) and 2-IV:5. Subjects that underwent additional PERG testing showed P50 reduction in keeping with severe macular involvement with evidence of progression in 4-II:1 (Supp. Figure S1 ).
Visual field testing was performed in six patients. Visual field defects corresponding to the amount of RPE atrophy were detected in these six patients, with a variable degree of interocular asymmetry. Constricted peripheral visual fields with relatively preserved central field were found in four patients (1-II:1, 4-II:1, 5-III:1, and 5-III:2), and large central field defects with areas of residual peripheral field were observed in two subjects (2-III:4 and 5-II:2). Generalized dyschromatopsia was detected in all four patients with available data (1-II:1, 2-III:4, 2-IV:5, and 5-II:2).
Sensorineural hearing loss was reported in three patients (Table 1) .
Hearing loss was first reported in childhood and diagnosed in two patients (3-II:1 and 4-II:1) and one subject showed severely reduced responses at the pure tone test in her 40s (5-II:2). Asymmetrical hearing loss was reported in one patient (4-II:1), while there were multiple infection histories in the middle ear.
Additional neurological abnormality was reported in three patients
(1-II:1, 5-II:2, and 5-III:2). Gait deficit was detected in one proband of family 1 (1-II:1), who was previously diagnosed with possible postpolio syndrome. The mother of this proband of family 1 (1-I:2) also had gait difficulty; however, detailed information is unavailable. Ataxia of gait was also detected in the proband of family 5 and her older daughter (5-II:2 and 5-III:1), while no ataxia was reported by the younger daughter (5-III:2). 
Identification of rare PRPS1 variants in affected females
The pedigrees of the study families are shown in predicted to be probably pathogenic by in silico prediction algorithms (Table 2) .
Variants in PRPS1 encoding the protein PRS-I cause rare forms of DFNX1, CMTX5, Arts syndrome, and PRS-I superactivity (MIM# 300661) in affected males (Gandia et al., 2015; Mittal, et al., 2015) . Figure S2 ).
The proband (GC19557, 3-II:1) of family 3 was diagnosed with RP and hearing loss, initially described as atypical Usher syndrome type II or III, with no family history of the condition. Known genes associated with Usher syndrome (MYO7A, USH1C, CDH23, PCDH15, USH1G, USH2A, GPR98, WHRN, CLRN1, and SLC4A7) were screened and variant negative (National Collaborative Usher Study (Stabej et al., 2012) ).
WES was performed and the variants were filtered and prioritized for all possible modes of inheritance (see Supp. Materials and Methods).
A unique variant in PRPS1 (GRCh37 ChrX:106888516; NM_002764:
c.640C > T (p.(Arg214Trp), RNA not analyzed)) was considered the most probable cause of disease. The variant was not found in the ExAC or gnomAD databases and was predicted to be potentially pathogenic by both Polyphen and SIFT (Table 2) . Interestingly, the same variant was identified in the proband of family 4 (GC19559, 4-II:1) who was (Table 2) . Sanger sequencing confirmed the variant in the proband and absence in her unaffected mother and sister (5-I:2 and 5-II:3). Two symptomatic daughters available for genetic testing were found to carry the PRPS1 variant (5-III:1 and 5-III:2, Figure 1 and Supp. Figure S2 ).
Pathogenicity and potential consequences of missense variants in PRPS1
All four rare PRPS1 missense variants (p.Ser16Phe, p.Arg196Trp, p.Arg214Pro, and p.Arg214Trp) identified in this study are absent from control datasets and are predicted to be damaging by both SIFT and Polyphen (with the exception of p.Arg214Pro, Table 2 ). Where samples were available, the variants segregated with the phenotype in families (Figure 1 and Supp. Figure S2 ). Multiple sequence alignment of PRS-I orthologues confirmed that the serine residue at position 16 and the arginine residues at positions 196 and 214 are highly conserved in orthologues at least to zebrafish ( Figure 4A ). PRS-I is highly conserved across different species, with 100% conservation in primates, wolf, cow, mouse, and rat, and over 88% conservation in insects.
Variants in PRPS1 have been previously associated with different phenotypes in males: DFNX1, CMTX5, Arts syndrome, PRS-I superactivity, and some overlapping phenotypes. Causative variants for these different hemizygous phenotypes have been identified in coding exons 2-7. In PRPS1 exon 1, only one variant (p.Ser16Pro) has been identified in a single family with only affected females ( Figure 4B ). The phenotypes associated with previously reported variants are summarized in Figure 4B .
PRPS1 codes for the enzyme PRS-I, a 318 amino acid protein that catalyzes the synthesis of phosphoribosyl pyrophosphate (PRPP) from ATP and ribose-5-phosphate (R5P) (Becker, 2001; . PRPP is essential for the de novo synthesis of purine (Hartman & Buchanan, 1958) , pyrimidine , and pyridine nucleotides (Preiss & Handler, 1958) . PRS-I acts as a hexamer, which consists of three homodimers arranged in a propeller-like shape ( Figure 5A ) (de Brouwer et al., 2010; Li, Lu, Peng, & Ding, 2007) . Each of the homodimers has an active site, comprising the binding site for ATP (including the flexible loop, the PPibinding loop, and the flag region) and R5P ( Figure 4B ), and two regulatory allosteric sites, I and II (de Brouwer et al., 2010; Li et al., 2007) .
Three-dimensional modelling of PRS-I indicates that serine 16 is located in the first -helix of the protein in the N-terminal domain, while the two affected arginine residues at position 196 and 214 are located in random coils ( Figure 5B-D) . Serine 16 has been previously predicted to create a hydrogen bond with Glycine 13 using Swiss
Model based on the PDB 2H06 model (Almoguera et al., 2014) . In the crystallography model, the side chain of Arginine 196 is in close proximity to the bound ATP, with a distance between the guanidinium group of the Arginine and the -phosphate of ATP of about 7.4Å (Li et al., 2007) . This close proximity suggests that Arginine 196 is involved in the interaction of PRS-I with the PPi, and in the stabilization of the transition state (Li et al., 2007) . The substitution of this conserved arginine with tryptophan has been previously predicted to abolish this interaction, resulting in decreased enzyme activity (Mittal et al., 2015) . ( Figure 4B ) and in the three-dimensional model the substitution of arginine 214 with tryptophan leads to the loss of a hydrogen bond with cysteine 165, possibly altering the binding site for R5P ( Figure 5C ).
The same hydrogen bond is lost with the substitution of arginine 214 to proline ( Figure 5D ). Therefore, all of the variants identified are predicted to either disrupt the function, or stability, of PRS-1.
DISCUSSION
Here, we characterize an IRD in five families in which only female members were affected, including cases with markedly asymmetrical disease on fundus examination, retinal imaging, and/or functional phenotyping. Variable clinical presentation was evident in the nine affected subjects, consistent with previous reports (Al-Maawali et al., 2015; Almoguera et al., 2014) , including variable disease onset and visual acuity, fundus appearance, and evidence of hearing loss and/or systemic abnormality. Almoguera and colleagues reported variable onset in six affected patients with PRPS1-associated disorders, including initial presentation of optic atrophy, night blindness, and reduced visual acuity, followed by presentation of RP, and later onset of hearing impairment and neurological abnormalities. In our five youngest cases (younger than 30 years at the latest examination), optic disc atrophy was observed in four, one had night blindness, and one had reduced visual acuity. Retinal atrophy was present at a wide range of ages in our cohort.
The absence of macular involvement was common, with maintained foveal structure and function observed even in a patient at the age • stimulus field), with maintained foveal structure and function (as was detected, and can be monitored over time, with multifocal ERG) (Almoguera et al., 2014; Fujinami et al., 2013) . Full-field ERGs showed a similar degree of generalized cone and rod photoreceptor dysfunction or predominant or selective cone system dysfunction and were normal in one young case (5-III:2). Overall, these observations demonstrate the importance of comprehensive assessment of both generalized retinal and macular structure and function in the diagnosis and monitoring of PRPS1 retinopathy.
Hearing impairment was reported in three patients (20-71 years at the latest examination) and systemic abnormalities were found in three (17-45 years). Our study also suggests earlier presentation of optic atrophy and later presentation of hearing impairment and systemic abnormalities; although there was still a degree of variability and further investigation with longitudinal analysis would be needed to confirm these observations. Overall, these findings illustrate that PRPS1-associated disorders can be progressive and affect multi- In a previous report (Almoguera et al., 2014) , skewed X chromosome inactivation was experimentally tested in blood leukocytes from three patients, whose symptoms included IRD. Only one of the affected individuals showed significant asymmetric inactivation that correlated with the severity of the phenotype. The lack of a skewed pattern of Xinactivation in two other subjects does not exclude this mechanism, as it may be tissue specific (Van den Veyver, 2001 ) and restricted to tissues primarily affected in this condition, i.e. the retina or the nervous system.
Interestingly, three affected individuals from families 3-5 also presented with hearing loss, caused by different missense variants affecting the same amino acid residue, p.Arg214Trp and p. Arg214Pro. These variants occurred de novo in families 4 (4-II:1) and 5 (5-II:2) and are the only variants reported in this study that are associated with hearing impairment.
In our study, disease progression was confirmed in the three affected females in family 5. Hearing loss and ataxia developed in the proband in her forties and ocular manifestations of retinal changes and disc pallor were first confirmed in the two affected daughters in their 20s. A progressive phenotype has previously been reported for affected females diagnosed with CMTX5 (Almoguera et al., 2014; Park et al., 2013; Synofzik et al., 2014) .
The majority of reported PRPS1 missense variants cause a reduction in PRS-I enzymatic activity (Almoguera et al., 2014; Gandia et al., 2015) . There is considerable variation in the resulting phenotype in hemizygous males, including DFNX1, CMTX5 disease, and Arts syndrome, and the phenotypic severity is considered to be related to the accompanied with a combination of neurodevelopment abnormalities, hypotonia, ataxia, and sensorineural hearing loss (Mittal et al., 2015) .
Although most female carriers in families with PRPS1 variants were noted to be asymptomatic (Kim et al., 2007) , some studies report that female carriers in families with Arts syndrome or CMTX5 occasionally exhibit delayed onset hearing impairment, sometimes combined with ataxia and neuropathy (Almoguera et al., 2014; Arts, Loonen, Sengers, & Slooff, 1993; de Brouwer et al., 2010; Kim et al., 2016; Liu et al., 2010; Synofzik et al., 2014) . In addition, a missense variant, p.Ser16Pro, has been reported in affected females in one family as the cause of optic atrophy, RP and neurological features overlapping CMTX5, and Arts syndrome, with no affected males (Almoguera et al., 2014) . The same amino acid residue is substituted in family 1 (p.Ser16Phe) with a similar phenotypic presentation.
While it has not been possible to experimentally confirm the PRS-I activity in our patients, the missense variant, p.Arg196Trp, in family 2 has been shown to reduce PRS-I enzymatic activity (Al-Maawali et al., 2015) . A similar decrease in enzymatic activity in females was reported for the missense variant p.Ser16Pro (Almoguera et al., 2014) , a different substitution at the same amino acid position affected in family 1 (p.Ser16Phe). It is likely that substitution at the same amino acid position will have a similar effect on PRS-I activity. The phenotype of families 3 (p.Arg214Trp), 4 (p.Arg214Trp), and 5 (p.Arg214Pro) is consistent a decrease in PRS-I enzymatic activity.
CONCLUSIONS
Skewed X-inactivation and/or variable levels of PRS-I deficiency or hyperactivity most likely contribute to the phenotypic variability of disease in males and females with missense variants in PRPS1. We speculate that the absence of affected males in the study families, and rarity of the variants in the population, suggests that some of these variants may not be tolerated when inherited in the hemizygous state in males and could be male embryonic lethal. Indeed, of the three affected amino acid positions 16, 196, and 214 that give rise to a phenotype in females, only one has been previously reported in affected males with the most severe phenotype caused by a PRPS1 variant; of four male children, only two survived the pregnancy and one died during childhood (Al-Maawali et al., 2015) . The phenotype included severe intellectual disability and spastic quadraparesis, macular coloboma-like lesions with retinal dystrophy, short stature, and diabetes insipidus. Alternatively selective involvement of females could be indicative of male sparing rather than male lethality (Ryan et al., 1997) .
The high conservation of the protein sequence is reflected in the lack of nucleotide variability across human genomes. In the ExAC database, there are no loss of function variants and only eight missense variants were identified in the major isoform, whereas a gene of similar size to PRPS1 would be expected to harbor on average 6.4
loss-of-function and 76.4 missense variants. The discrepancy between observed and expected variant rate leads to this gene having a high probability of loss-of-function intolerance (pLI = 0.87) (Lek et al., 2016) . If population variability is only considered for hemizygous variants, the number of variants drops even further with only one missense variant identified in PRPS1 in the general population.
To date, only variants at amino acid position 16, 196, and 214 have been associated with a retinopathy. More patients need to be investigated both genetically and phenotypically before it will be possible to reach any conclusion on the specific role of these residues, or the relationship between specific domains of PRS-I and retinal function.
Patients with Arts syndrome have shown an encouraging response to a trial intervention with S-adenosylmethionine (SAM), as a substrate for the alternative purine synthesis pathway (de Brouwer et al., 2010; Liu et al., 2013) . SAM can replenish ATP and GTP independently of PRPP by direct conversion into adenine via the polyamine pathway. In addition, methyltransferases convert SAM into S-adenosylhomocysteine, which can be transformed into adenosine and adenine by S-adenosylhomocysteine hydrolase (de Brouwer et al., 2010) . Treatment with SAM could therefore be considered for patients with PRPS1 retinopathy to potentially slow the progression of retinal degeneration.
This report highlights the unexpected finding of retinal degeneration in females caused by missense variants in the X-linked gene PRPS1
and expands our understanding of the phenotypic outcome of specific variants. The features of retinal degeneration include RPE mottling described as a tapetal-like reflex and intraocular asymmetry, and are similar to those seen in some female carriers of RPGR and RP2 (Ebenezer et al., 2005; Kousal et al., 2014; Pelletier et al., 2007; Tee, Smith, Hardcastle, & Michaelides, 2016) , and PRPS1 should be considered in females with such generalized retinal dystrophy after exclusion of the more common causes, especially in the absence of affected males in an extended family.
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